The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers ...

The U.S. Department of Health and Human Services Office of Inspector General (OIG) once again addressed an industry-sponsored genetic testing program, posting a favorable decision on July 2, 2025 in ...

The universe of precision medicine in oncology is large and expanding. With new targeted drugs and companion testing, people with mutation-driven cancers now have care opportunities that have never ...

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company ...